20.02.2014 • NewsautomotiveBelgiumIneos

Ineos Expands ENB Plant in Belgium

Through debottlecking, Ineos has increased its capacity for ethylene norbonene (ENB) at Zwijndrecht, Belgium, to 28,000 t/y. The company said the plant is now the largest of its kind in the world.

Hans Casier, CEO of Ineos Oxide said ongoing global growth and demand from new ENB customers, especially producers of ethylene-propylene-diene (EPDM) rubber, requires new capacity. The expansion at the site near Antwerp will provide sufficient output for the next two to three years, he said.

Products are sold to the automotive, white goods and construction industries. With facilities in Antwerp, as well as Cologne, Germany, Lavera France, Plaquemine, Louisiana in the U.S. and Hull in the UK, Ineos Oxide is also a leading producer of ethylene oxide and derivatives. The portfolio also includes propylene oxide and derivatives, in addition to solvents and specialty chemicals.

 

 

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

most read

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.